Stand‐alone model for delivery of oral HIV pre‐exposure prophylaxis in Kenya: a single‐arm, prospective pilot evaluation
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Introduction: The delivery of daily, oral HIV pre‐exposure prophylaxis (PrEP) at private pharmacies may overcome barriers to PrEP delivery at public healthcare facilities, including HIV‐associated stigma, long wait times and overcrowding. Methods: At five private, community‐based pharmacies in Kenya, a care pathway for PrEP delivery (ClinicalTrials.gov: NCT04558554) was piloted—the first of its kind in Africa. Pharmacy providers screened clients interested in PrEP for HIV risk, then used a prescribing checklist to identify clients without medical conditions that might contraindicate PrEP safety, counsel them on PrEP use and safety, conduct provider‐assisted HIV self‐testing and dispense PrEP. For complex clinical cases, a remote clinician was available for consultation. Clients who did not meet the checklist criteria were referred to public facilities for free services delivered by clinicians. Pharmacy providers dispensed a 1‐month PrEP supply at initiation and a 3‐month supply thereafter at a client fee of 300 KES (∼$3 USD) per visit. Results: From November 2020 to October 2021, pharmacy providers screened 575 clients, identified 476 who met the prescribing checklist criteria and initiated 287 (60%) on PrEP. Among pharmacy PrEP clients, the median age was 26 years (IQR 22–33) and 57% (163/287) were male. The prevalence of behaviours associated with HIV risk among clients was high; 84% (240/287) reported sexual partners with unknown HIV status and 53% (151/287) reported multiple sexual partners (past 6 months). PrEP continuation among clients was 53% (153/287) at 1 month, 36% (103/287) at 4 months and 21% (51/242) at 7 months. During the pilot observation period, 21% (61/287) of clients stopped and restarted PrEP and overall pill coverage was 40% (IQR 10%–70%). Nearly, all pharmacy PrEP clients (≥96%) agreed or strongly agreed with statements regarding the acceptability and appropriateness of pharmacy‐delivered PrEP services. Conclusions: Findings from this pilot suggest that populations at HIV risk frequently visit private pharmacies and PrEP initiation and continuation at pharmacies is similar to or exceeds that at public healthcare facilities. Private pharmacy‐based PrEP delivery, conducted entirely by private‐sector pharmacy staff, is a promising new delivery model that has the potential to expand PrEP reach in Kenya and similar settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-010-0319-7 · Cited by 8,721 · cited 2×
“Acceptability—the perception an intervention is agreeable, palatable or satisfactory [36]—was measured using four statements that assess different component constructs of the Theoretical Framework of Acceptability (e.”
MethodSekhon, M., Cartwright, M., & Francis, J. J. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2031-8 · Cited by 3,938
Psychometric assessment of three newly developed implementation outcome measures
Weiner, B. J., Lewis, C. C., Stanick, C., Powell, B. J., Dorsey, C. N., Clary, A. S., Boynton, M. H., & Halko, H. (2017) · Implementation Science · doi:10.1186/s13012-017-0635-3 · Cited by 2,819
Sharma, M., Ying, R., Tarr, G., & Barnabas, R. (2015) · Nature · doi:10.1038/nature16044 · Cited by 491
Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women.
Nel, A., van Niekerk, N., Kapiga, S., Bekker, L.-G., Gama, C., Gill, K., Kamali, A., Kotze, P., Louw, C., Mabude, Z., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602046 · Cited by 479 · cited 1×
“the vaginal ring [59, 60] and injectable PrEP [61, 62]), a key priority should be ensuring that these products are available in the community where people need them.”
BackgroundIrungu, E. M., Mugwanya, K. K., Mugo, N. R., Bukusi, E. A., Donnell, D., Odoyo, J., Wamoni, E., Peacock, S., Morton, J. F., Ngure, K., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00391-0 · Cited by 49 · cited 3×
“In the Partners Scale-up Project, an implementation study of PrEP delivery at 25 public HIV clinics in Kenya over 30 months (January 2017–June 2019), PrEP continuation was 57% (2806/4898), 44% (2135/4898) and 34% (1661/4898) at 1, 3 and 6 months [40]—similar to what was observed in this pilot [40].”
BackgroundResultInfluentialSelf-citation
Research works printed but not linked: 41
- 10.1007/s11904-019-00437-6 · DOI · Paper page
- 10.1016/S2352-3018(18)30178-4 · DOI
- 10.1371/journal.pmed.1002099 · DOI · Paper page
- 10.1001/jamanetworkopen.2019.9818 · DOI · Paper page
- 10.1007/s10461-021-03229-5 · DOI
- 10.1186/1472-6963-14-231 · DOI
- 10.1186/s12913-020-05898-9 · DOI
- 10.1056/NEJMp1714773 · doi:10.1056/nejmp1714773
- 10.1007/s11904-016-0326-8 · doi:10.1007/s11904-016-0326-8
- 10.1080/09540121.2020.1782328 · DOI
- 10.1002/jia2.25619 · doi:10.1002/jia2.25619
- 10.2146/ajhp080483 · DOI
- 10.1071/SH18090 · DOI · Paper page
- 10.1071/SH18084 · DOI
- 10.7196/SAMJ.2021.v111i12.16262 · doi:10.7196/samj.2021.v111i12.16262
- Ortblad K, 2021, Design of a care pathway for pharmacy‐based PrEP delivery in Kenya: results from a collaborative stakeholder consultation, J Int AIDS Soc, 24, 92
- 10.1002/jia2.25426 · DOI
- 10.1002/jia2.25378 · doi:10.1002/jia2.25378
- Irungu EM, 2018, Rapid scale‐up of PrEP for HIV serodiscordant couples in HIV care clinics in Kenya, Top Antivir Med, 26, 483s
- 10.1002/jia2.25827 · DOI
- 10.3389/fphar.2019.00721 · DOI
- 10.1007/s11904-009-0024-x · DOI · Paper page
- 10.1007/s10461-022-03796-1 · DOI
- 10.1371/journal.pmed.1002885 · DOI · Paper page
- 10.1016/S2352-3018(19)30335-2 · DOI · Paper page
- 10.1002/jia2.25845 · DOI
- 10.12688/gatesopenres.13342.1 · doi:10.12688/gatesopenres.13342.1
- 10.1016/S2352-3018(22)00126-6 · DOI · Paper page
- 10.1002/jia2.25561 · doi:10.1002/jia2.25561
- 10.1111/j.1728-4465.2004.00014.x · DOI · Paper page
- 10.1016/j.ijid.2022.04.038 · DOI
- 10.1097/QAI.0000000000001656 · DOI
- 10.7448/IAS.18.2.19408 · DOI · Paper page
- 10.1097/COH.0000000000000569 · DOI
- 10.3389/fpubh.2020.00303 · DOI
- 10.1002/jia2.26055 · DOI
- 10.1016/j.japh.2019.06.021 · DOI
- 10.1016/S2352-3018(21)00129-6 · doi:10.1016/s2352-3018(21)00129-6
- 10.1056/NEJMoa1506110 · DOI · Paper page
- 10.1056/NEJMoa2101016 · DOI · Paper page
- 10.1016/S0140-6736(22)00538-4 · DOI · Paper page
Metadata
- Authors
- Ortblad, K. F., Mogere, P., Omollo, V., Kuo, A. P., Asewe, M., Gakuo, S., Roche, S., Mugambi, M., Mugambi, M. L., Stergachis, A., Odoyo, J., Bukusi, E. A., Ngure, K., & Baeten, J. M.
- Venue
- Journal of the International AIDS Society
- Publisher
- Wiley
- Published
- 2023-06
- Volume
- 26
- Issue
- 6
- ISSN
- 1758-2652
- Cited by
- 38
- References
- 6
- Language
- en
- Update notices
- correction (2023-08-29)
- Funders
- National Institute of Mental Health (R34 MH120106, K99 MH121166)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.